These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4399389)

  • 21. Potentiation of bronchomotor responses by beta adrenergic antagonists.
    Diamond L
    J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of an adrenergic beta receptor blockader (D(-)INPEA) on various functional parameters of the rabbit heart].
    Arrigo L; Macrì I; Rigon-Macrì P
    Boll Soc Ital Biol Sper; 1971 Oct; 47(20):647-50. PubMed ID: 4401207
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-activity relationship of the beta adrenoreceptor blocking agents.
    Laddu AR; Somani P
    Eur J Pharmacol; 1969 Nov; 8(2):167-70. PubMed ID: 4391503
    [No Abstract]   [Full Text] [Related]  

  • 25. New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.
    Boissier JR; Ratouis R; Dumont C; Derible PH; Lavaux JP
    J Med Chem; 1970 Sep; 13(5):971-3. PubMed ID: 4394057
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

  • 27. Surface tension effects of beta-adrenergic blocking drugs.
    Levy JV
    J Pharm Pharmacol; 1968 Oct; 20(10):813-5. PubMed ID: 4386761
    [No Abstract]   [Full Text] [Related]  

  • 28. Action of catecholamines and anti-adrenergic drugs on isolated short-circuited frog skin.
    Fassina G; Fiandini G; Carpenedo F; Santi R
    Comp Gen Pharmacol; 1971 Mar; 2(5):27-35. PubMed ID: 4147037
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of beta adrenergic blocking agents on stress induced changes in acetylcholine content of rat's myocardium.
    Khanna NK; Madan BR
    Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):136-40. PubMed ID: 4387237
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of adrenergic blocking drugs on central angiotensin effects.
    Severs WB; Summy-Long J; Daniels-Severs A; Connor JD
    Pharmacology; 1971; 5(4):205-14. PubMed ID: 4397328
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of beta adrenoceptor blocking agents on the membrane potential and spike generation in the smooth muscle of guinea-pig taenia coli.
    Davis WG
    Br J Pharmacol; 1970 Jan; 38(1):12-9. PubMed ID: 4391730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of beta-adrenergic receptor blockade on the blood pressure and heart rate changes induced by noradrenaline infusion and postinfusional hypotension.
    Mazurkiewicz IM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):136-58. PubMed ID: 4384633
    [No Abstract]   [Full Text] [Related]  

  • 34. The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.
    Loubatières A; Mariani MM; Sorel G; Savi L
    Diabetologia; 1971 Jun; 7(3):127-32. PubMed ID: 4397807
    [No Abstract]   [Full Text] [Related]  

  • 35. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 36. Antioxytocin activity of propranolol, INPEA and their optical isomers on the isolated rat uterus.
    Saini RK; Sharma PL
    Eur J Pharmacol; 1971 May; 14(4):399-401. PubMed ID: 4400536
    [No Abstract]   [Full Text] [Related]  

  • 37. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective beta adrenergic receptor blockade in the rat.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1972 Aug; 182(2):256-63. PubMed ID: 4403093
    [No Abstract]   [Full Text] [Related]  

  • 39. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 40. Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.
    Levy JV
    Eur J Pharmacol; 1968 Feb; 2(4):250-7. PubMed ID: 4384450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.